Gland Pharma Limited (GLAND.NS)

INR 1764.95

(0.06%)

Annual Cash Flows

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Operating Cash Flow 11.08 Billion 3.63 Billion 7.9 Billion 6.04 Billion 7 Billion 1.85 Billion
Net Income 7.72 Billion 10.54 Billion 16.18 Billion 13.34 Billion 9.92 Billion 6.86 Billion
Depreciation & Amortization 3.44 Billion 1.46 Billion 1.1 Billion 987.8 Million 945.87 Million 821.2 Million
Deferred income taxes - - -4.14 Billion -3.25 Billion -2.77 Billion -
Stock-based compensation - - 46.21 Million 155.34 Million 164.84 Million -
Change in working capital -531.99 Million -4.17 Billion -3.93 Billion -4.35 Billion -799.42 Million -3.53 Billion
Other non-cash items 7.71 Billion -4.19 Billion -1.35 Billion -830.38 Million -452.35 Million -2.29 Billion
Investing Cash Flow -18.93 Billion 12.08 Billion -10.02 Billion -15.24 Billion -7.66 Billion -3.14 Billion
Investments in PPE -3.98 Billion -2.23 Billion -5.22 Billion -2.28 Billion -1.94 Billion -1.35 Billion
Acquisitions -10.2 Billion -12.7 Billion 6.11 Billion 4.3 Million 238.86 Million 5.45 Million
Investment purchases -7.4 Billion -4.69 Billion -16.81 Billion -13.57 Billion -6.38 Billion -2.18 Billion
Sales/Maturities of investments 2.65 Billion 17.4 Billion 10.7 Billion -4.3 Million -238.86 Million -5.45 Million
Other Investing Activities -3.45 Billion 14.31 Billion -4.8 Billion 623.67 Million 673.33 Million 403.5 Million
Financing Cash Flow -7.73 Billion 149.19 Million 348.98 Million 12.38 Billion -68.71 Million -31.24 Million
Debt repayment -7.56 Billion -1.12 Million -1.36 Million -8.91 Million -5.3 Million -4.25 Million
Dividends payments - - - - - -
Common Stock Repurchased - - - - - -
Common Stock Issuance 5.26 Million 214.96 Million 385.52 Million 12.41 Billion - -
Other Financing Activities -250.85 Million -64.65 Million -35.18 Million -24.56 Million -63.41 Million -26.99 Million
Accounts receivables -3.24 Billion 1.43 Billion -4.19 Billion -602.01 Million -805.17 Million -458.96 Million
Accounts payables -3.78 Billion 1.2 Billion 658.46 Million 1.42 Billion -2.14 Billion 1.13 Billion
Inventory 6.66 Billion -7.59 Billion 895.01 Million -5.18 Billion 1.55 Billion -3.99 Billion
Other working capital -154.51 Million 767.19 Million -1.28 Billion 5.14 Million 596.51 Million -220.15 Million
Cash at beginning of period 19.08 Billion 3.18 Billion 4.92 Billion 1.69 Billion 2.36 Billion 3.72 Billion
Cash at end of period 18.39 Billion 19.08 Billion 3.18 Billion 4.92 Billion 1.69 Billion 2.36 Billion
Capital Expenditure -3.98 Billion -2.23 Billion -5.22 Billion -2.28 Billion -1.94 Billion -1.35 Billion
Effect of forex changes on cash 77.23 Million 30 Million 33.11 Million 35.77 Million 51.09 Million -44.31 Million
Net cash flow / Change in cash -694.63 Million 15.9 Billion -1.73 Billion 3.22 Billion -669.05 Million -1.36 Billion
Free Cash Flow 7.09 Billion 1.4 Billion 2.68 Billion 3.76 Billion 5.06 Billion 495.11 Million

Cash Flow Charts